Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2015-06-17
DOI
10.1155/2015/794968
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer
- (2014) Manja Idorn et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients
- (2014) Jingwei Jiang et al. HUMAN IMMUNOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer-related inflammation and treatment effectiveness
- (2014) Connie I Diakos et al. LANCET ONCOLOGY
- Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
- (2014) Eugene D Kwon et al. LANCET ONCOLOGY
- The Role of M1 and M2 Macrophages in Prostate Cancer in relation to Extracapsular Tumor Extension and Biochemical Recurrence after Radical Prostatectomy
- (2014) M. Lanciotti et al. Biomed Research International
- From Bench to Bedside: Immunotherapy for Prostate Cancer
- (2014) Brian Wan-Chi Tse et al. Biomed Research International
- Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models
- (2014) L. Shen et al. Cancer Immunology Research
- Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
- (2014) Theerawut Chanmee et al. Cancers
- Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
- (2013) S. F. Slovin et al. ANNALS OF ONCOLOGY
- Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
- (2013) A. J. Armstrong et al. CLINICAL CANCER RESEARCH
- Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer
- (2013) Ngar-Yee Huen et al. INTERNATIONAL JOURNAL OF CANCER
- Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy
- (2013) C G Drake et al. ONCOGENE
- Tumoricidal activity of human dendritic cells
- (2013) Jurjen Tel et al. TRENDS IN IMMUNOLOGY
- Lower Baseline Prostate-specific Antigen Is Associated With a Greater Overall Survival Benefit From Sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) Trial
- (2013) Paul F. Schellhammer et al. UROLOGY
- Natural and Induced T Regulatory Cells in Cancer
- (2013) Dennis O. Adeegbe et al. Frontiers in Immunology
- Increased CD8+ T-cell Function following Castration and Immunization Is Countered by Parallel Expansion of Regulatory T Cells
- (2012) S. Tang et al. CANCER RESEARCH
- Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment
- (2012) J. T. Isaacs et al. CANCER RESEARCH
- T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
- (2012) A. Facciabene et al. CANCER RESEARCH
- Helper T cell diversity and plasticity
- (2012) Shingo Nakayamada et al. CURRENT OPINION IN IMMUNOLOGY
- High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer
- (2012) Anna Flammiger et al. EUROPEAN JOURNAL OF CANCER
- Influence of human immune cells on cancer: studies at the University of Colorado
- (2012) Tullia C. Bruno et al. IMMUNOLOGIC RESEARCH
- Myeloid-Derived Suppressor Cells and anti-tumor T cells: a complex relationship
- (2012) Ngozi R. Monu et al. IMMUNOLOGICAL INVESTIGATIONS
- Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
- (2012) Alfons JM van den Eertwegh et al. LANCET ONCOLOGY
- Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
- (2012) Ravi A Madan et al. LANCET ONCOLOGY
- Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
- (2012) Suzanne Ostrand-Rosenberg et al. SEMINARS IN CANCER BIOLOGY
- Integration of immunotherapy into the management of advanced prostate cancer
- (2012) Philip Kantoff et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Sipuleucel-T for the treatment of metastatic prostate cancer
- (2012) Channing J. Paller et al. Human Vaccines & Immunotherapeutics
- An overview of sipuleucel-T: Autologous cellular immunotherapy for prostate cancer
- (2012) Johnna Wesley et al. Human Vaccines & Immunotherapeutics
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Prostate cancer and inflammation: the evidence
- (2011) Karen S Sfanos et al. HISTOPATHOLOGY
- Phase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
- (2011) Roberto Pili et al. JOURNAL OF CLINICAL ONCOLOGY
- Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts
- (2011) Susan L. Dalrymple et al. PROSTATE
- Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer
- (2010) Norio Nonomura et al. BJU INTERNATIONAL
- Cellular Vaccine Approaches
- (2010) Dung T. Le et al. CANCER JOURNAL
- The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
- (2010) Je-In Youn et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Prognostic significance of regulatory T cells in tumor
- (2010) Cailin Moira Wilke et al. INTERNATIONAL JOURNAL OF CANCER
- Regulatory T cells in tumor immunity
- (2010) Hiroyoshi Nishikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
- (2009) Celestia S. Higano et al. CANCER
- Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
- (2009) P.-Y. Pan et al. CANCER RESEARCH
- Immunotherapy for Prostate Cancer: Walk, Don't Run
- (2009) Charles G. Drake JOURNAL OF CLINICAL ONCOLOGY
- Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells
- (2009) E. M. Hanson et al. JOURNAL OF IMMUNOLOGY
- Immunosuppressive CD14+HLA-DRlow/−monocytes in prostate cancer
- (2009) Stanimir Vuk-Pavlović et al. PROSTATE
- Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
- (2008) K. Movahedi et al. BLOOD
- Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer
- (2008) Celestia S. Higano et al. CANCER
- Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma
- (2008) Mahmoud-Rezk A. Hussein et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
- (2008) Paulo C. Rodríguez et al. IMMUNOLOGICAL REVIEWS
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
- Regulatory T Cells: Mechanisms of Differentiation and Function
- (2007) Steven Z. Josefowicz et al. Annual Review of Immunology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now